That's true, but it's a terrible way to express the outcome of the FDA's regulatory action. During the pandemic, the FDA granted themselves the ability to establish a third regulatory outcome, a Decline, to add to the binary outcomes of Deny or Approve. So my first sentence conflates two different outcomes. And that's exactly what the SEC did in their Indictment.